SCHEMBL20150385

SCHEMBL20150385

Cc1cccc(-c2ccc3c(c2)c2cc(-c4cccc(C)c4)ccc2n3-c2ccc(C#N)cc2-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.39
CYP3A4 P08684 3/20 0.39
ALDH1A1 P00352 3/20 0.39
TSHR P16473 3/20 0.39
MEN1 O00255 2/20 0.39
CYP2C19 P33261 2/20 0.39
KMT2A Q03164 2/20 0.39
CLK4 Q9HAZ1 2/20 0.39
CYP2D6 P10635 2/20 0.39
LMNA P02545 2/20 0.39
CYP2C9 P11712 2/20 0.39
HSD17B10 Q99714 2/20 0.39
ABCG2 Q9UNQ0 6/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
ALDH1A3 P47895 1/20 0.37
PTGER4 P35408 1/20 0.37
GABRA1 P14867 2/20 0.37
GABRA5 P31644 2/20 0.37
GABRA3 P34903 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21089841 1.00 CYP1A2 (0.39) CYP1A2CYP3A4ALDH1A1TSHRMEN1
SCHEMBL20150386 0.97 PTGER4 (0.41) CYP1A2CYP3A4ALDH1A1TSHRMEN1
SCHEMBL21090884 0.97 PTGER4 (0.41) CYP1A2CYP3A4ALDH1A1TSHRMEN1
SCHEMBL21090046 0.94 ABCG2 (0.37) CYP1A2CYP3A4ALDH1A1TSHRMEN1
SCHEMBL20150397 0.94 ABCG2 (0.37) CYP1A2CYP3A4ALDH1A1TSHRMEN1
SCHEMBL21089842 0.93 PTGER4 (0.35) CYP1A2CYP3A4ALDH1A1TSHRMEN1
SCHEMBL21364454 0.93 CYP1A2 (0.41) CYP1A2CYP3A4ALDH1A1TSHRMEN1
SCHEMBL22243193 0.93 CYP1A2 (0.41) CYP1A2CYP3A4ALDH1A1TSHRMEN1
SCHEMBL20150414 0.93 KDM4E (0.39) CYP1A2CYP3A4ALDH1A1TSHRMEN1
SCHEMBL27015777 0.92 CYP1A2 (0.42) CYP1A2CYP3A4ALDH1A1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 CYP1A2 659/4885CYP3A4 950/4885ALDH1A1 387/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 CYP1A2 659/4885CYP3A4 950/4885ALDH1A1 387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.